WYMZYA Fe NDC 68180-873

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-873Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0873Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-873-73	68180087373	3 POUCH in 1 CARTON (68180-873-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK * 21 TABLET, CHEWABLE in 1 BLISTER PACK (68180-832-74) * 7 TABLET in 1 BLISTER PACK (68180-856-74)Marketed from Nov 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): WYMZYA Fe
Generic name (nonproprietary): norethindrone and ethinyl estradiol
Dosage form: Kit
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091332
Marketing start: Nov 30, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 68180-873_a3be3d49-c5f9-4700-b928-317b0289391fSPL ID a3be3d49-c5f9-4700-b928-317b0289391fSPL set ID 4f824b11-14f3-4a92-a516-562b3a434df0RxCUI 433718, 1095223, 1095224, 1486452UPC 0368180873716

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N468180087373 followed by a unit qualifier and the quantity

Package 68180-0873-73. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 19, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

WYMZYA TM Fe is indicated for use by females of reproductive potential to prevent pregnancy. WYMZYA Fe is a progestin/estrogen COC indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)